The US Food and Drug Administration (FDA) has granted 510(k) clearance to Teleflex Incorporated to market its new ARROW FlexBlock continuous peripheral nerve block catheter in the US.

The FlexBlock’s catheter tip design enables physicians to spread the anesthetic easily, while the polyurethane- constructed echogenic, coil-reinforced catheter body offers a combination of ultrasound visibility, flexibility, and excellent kink resistance.

Teleflex anesthesia and respiratory division president Cary Vance said the company is adding the newly introduced FlexBlock catheter to its product line of ARROW StimuCath continuous peripheral nerve block catheters.

"These products, in addition to the StimuQuik ECHO peripheral nerve block needles, SureBlock spinal trays, and the recently 510(k) cleared FlexTip Plus Multi-Port epidural catheters, give Teleflex a clinically differentiated regional anesthesia product portfolio, designed to meet the needs of anesthesiologists in the field of regional anesthesia and acute pain management," Vance added.